Cargando…

NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications

BACKGROUND: Primary melanocytic neoplasms are rare in the pediatric age. Among them, the pattern of neoplastic meningitis represents a peculiar diagnostic challenge since neuroradiological features may be subtle and cerebrospinal fluid analysis may not be informative. Clinical misdiagnosis of neopla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Angelino, Giulia, De Pasquale, Maria Debora, De Sio, Luigi, Serra, Annalisa, Massimi, Luca, De Vito, Rita, Marrazzo, Antonio, Lancella, Laura, Carai, Andrea, Antonelli, Manila, Giangaspero, Felice, Gessi, Marco, Menchini, Laura, Scarciolla, Laura, Longo, Daniela, Mastronuzzi, Angela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955223/ https://www.ncbi.nlm.nih.gov/pubmed/27439913 http://dx.doi.org/10.1186/s12885-016-2556-y

Ejemplares similares

Liquid Biopsy with Detection of NRAS(Q61K) Mutation in Cerebrospinal Fluid: An Alternative Tool for the Diagnosis of Primary Pediatric Leptomeningeal Melanoma
por: Mastronuzzi, Angela, et al.
Publicado: (2022)

PATH-19. MOLECULAR CLASSIFICATION BASED ON THE DNA METHYLATION PROFILE OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS IN CHILDREN: TWO-YEARS EXPERIENCE AT THE BAMBINO GESÙ HOSPITAL
por: Miele, Evelina, et al.
Publicado: (2020)

Expanding the spectrum of EWSR1‐PATZ1 rearranged CNS tumors: An infantile case with leptomeningeal dissemination
por: Rossi, Sabrina, et al.
Publicado: (2021)

NRAS(Q61R), BRAF(V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas
por: Uguen, Arnaud, et al.
Publicado: (2015)

Transcriptome of melanoma cells from two mouse models, Tyr:NRas(Q61K)and Tyr:Rack1-HA, Tyr:NRas(Q61K)
por: Campagne, Cécil, et al.
Publicado: (2017)

Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent
por: del Bufalo, Francesca, et al.
Publicado: (2014)

Variation of mutant allele frequency in NRAS Q61 mutated melanomas
por: Hélias-Rodzewicz, Zofia, et al.
Publicado: (2017)

HGG-09. MicroRNAs expression profile in Meningioma 1 (MN1) gene altered astroblastoma
por: Antonelli, Manila, et al.
Publicado: (2022)

Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features
por: Mastronuzzi, Angela, et al.
Publicado: (2014)

Introduction
por: Barbareschi, Mattia, et al.
Publicado: (2022)

Multiple Congenital Melanocytic Nevi and Neurocutaneous Melanosis Are Caused by Postzygotic Mutations in Codon 61 of NRAS
por: Kinsler, Veronica A, et al.
Publicado: (2013)

The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRAS(Q61K) melanoma
por: Simbulan-Rosenthal, Cynthia M., et al.
Publicado: (2017)

Numb Isoforms Deregulation in Medulloblastoma and Role of p66 Isoform in Cancer and Neural Stem Cells
por: Abballe, Luana, et al.
Publicado: (2018)

Loss of miR-107, miR-181c and miR-29a-3p Promote Activation of Notch2 Signaling in Pediatric High-Grade Gliomas (pHGGs)
por: Catanzaro, Giuseppina, et al.
Publicado: (2017)

Activated Mutant NRas(Q61K) Drives Aberrant Melanocyte Signaling, Survival, and Invasiveness via a Rac1-Dependent Mechanism
por: Li, Ang, et al.
Publicado: (2012)

Dural-based atypical teratoid/rhabdoid tumor in an adult: DNA methylation profiling as a tool for the diagnosis
por: Hiba, Alzoubi, et al.
Publicado: (2020)

Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup
por: Miele, Evelina, et al.
Publicado: (2015)

Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification
por: Gianno, Francesca, et al.
Publicado: (2022)

MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression
por: Catanzaro, Giuseppina, et al.
Publicado: (2022)

BRAF activation by metabolic stress promotes glycolysis sensitizing NRAS(Q61)-mutated melanomas to targeted therapy
por: McGrail, Kimberley, et al.
Publicado: (2022)

P858: FUNCTIONAL STUDIES IN MULTIPLE MYELOMA CELL LINESWITH OVEREXPRESSION OF NRAS Q61R MUTATION
por: Liotti, Romano, et al.
Publicado: (2023)

Primary leptomeningeal oligodendrogliomatosis
por: Mathews, Marlon S., et al.
Publicado: (2009)

Mutant NRAS(Q61) shares signaling similarities across various cancer types – potential implications for future therapies
por: Vujic, Igor, et al.
Publicado: (2014)

Clinically relevant genes and regulatory pathways associated with NRAS(Q61) mutations in melanoma through an integrative genomics approach
por: Jiang, Wei, et al.
Publicado: (2014)

Rapid progression to AML in a patient with germline GATA2 mutation and acquired NRAS Q61K mutation
por: McReynolds, Lisa J., et al.
Publicado: (2019)

Sella Turcica Atypical Teratoid/Rhabdoid Tumor Complicated with Lung Metastasis in an Adult Female
por: Moretti, Costanzo, et al.
Publicado: (2013)

Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor
por: Modena, Piergiorgio, et al.
Publicado: (2013)

Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma
por: Kumar, Raj, et al.
Publicado: (2019)

Nras(Q61R/+) and Kras(−/−) cooperate to downregulate Rasgrp1 and promote lympho-myeloid leukemia in early T-cell precursors
por: Wen, Zhi, et al.
Publicado: (2021)

Intradural Pediatric Spinal Tumors: An Overview from Imaging to Novel Molecular Findings
por: Marrazzo, Antonio, et al.
Publicado: (2021)

ODP465 BRAF V600 and NRAS Q61 mutations in thyroid fine-needle aspiration (FNA) with indeterminate cytology in Argentina
por: Repetto, Esteban M, et al.
Publicado: (2022)

Editorial: Pediatric Central Nervous System Tumors: State-of-the-Art and Debated Aspects
por: Carai, Andrea, et al.
Publicado: (2020)

Congenital Craniofacial Plexiform Neurofibroma in Neurofibromatosis Type 1
por: Cacchione, Antonella, et al.
Publicado: (2021)

NSD1 Mutations and Pediatric High-Grade Gliomas: A Comparative Genomic Study in Primary and Recurrent Tumors
por: d’Amati, Antonio, et al.
Publicado: (2022)

Invasive follicular variant of papillary thyroid cancer harboring the NRAS mutation Q61K and presenting with bone metastasis—A case report
por: Mehrzad, Raman, et al.
Publicado: (2017)

Transient global ventricular dysfunction in an adolescent affected by pancreatic adenocarcinoma
por: De Pasquale, Maria Debora, et al.
Publicado: (2016)

Molecular Landscape in Infant High-Grade Gliomas: A Single Center Experience
por: Di Ruscio, Valentina, et al.
Publicado: (2022)

No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC)
por: Capelli, Laura, et al.
Publicado: (2016)

NRAS mutant melanoma – undrugable?
por: Posch, Christian, et al.
Publicado: (2013)

CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies
por: Antonucci, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vobn6ld1rfoeank05rg0q1rr01